Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib dosing in hand osteoarthritis
NCT03067194Phase 4Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Dec 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of celecoxib oral solution in osteoarthritis (OA), sponsored by Chong Kun Dang Holdings. Started Dec 2016; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03067194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067194.